{"id":"https://openalex.org/W2073623971","doi":"https://doi.org/10.1016/j.clinthera.2013.08.003","title":"Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study","display_name":"Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study","publication_year":2013,"publication_date":"2013-09-18","ids":{"openalex":"https://openalex.org/W2073623971","doi":"https://doi.org/10.1016/j.clinthera.2013.08.003","mag":"2073623971","pmid":"https://pubmed.ncbi.nlm.nih.gov/24054830"},"language":"en","primary_location":{"id":"doi:10.1016/j.clinthera.2013.08.003","doi":"https://doi.org/10.1016/j.clinthera.2013.08.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2013.08.003","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.clinthera.2013.08.003","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112341927","display_name":"Heino Sta\u00df","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heino Stass","raw_affiliation_strings":["Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany. Electronic address: heino.stass@bayer.com","Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany. Electronic address: heino.stass@bayer.com","institution_ids":[]},{"raw_affiliation_string":"Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015913879","display_name":"Boris Weimann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boris Weimann","raw_affiliation_strings":["Chrestos Concept GmbH & Co. KG, Ratingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chrestos Concept GmbH & Co. KG, Ratingen, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030390918","display_name":"Johannes Nagelschmitz","orcid":"https://orcid.org/0000-0002-1039-3173","observed_orcids":["https://orcid.org/0000-0002-1039-3173"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Nagelschmitz","raw_affiliation_strings":["Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Pharma AG, Global Drug Discovery, Development Clinical Pharmacology, Cardiovascular/Primary Care, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030045117","display_name":"Claudia Rolinck\u2010Werninghaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claudia Rolinck-Werninghaus","raw_affiliation_strings":["Pediatric Pneumology and Immunology, Charit\u00e9 University Hospital, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Pneumology and Immunology, Charit\u00e9 University Hospital, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089614991","display_name":"Doris Staab","orcid":"https://orcid.org/0009-0008-0024-671X","observed_orcids":["https://orcid.org/0009-0008-0024-671X"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Doris Staab","raw_affiliation_strings":["Pediatric Pneumology and Immunology, Charit\u00e9 University Hospital, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pediatric Pneumology and Immunology, Charit\u00e9 University Hospital, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4240,"currency":"USD","value_usd":4240},"apc_paid":{"value":4240,"currency":"USD","value_usd":4240},"fwci":6.7702,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.97145325,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"35","issue":"10","first_page":"1571","last_page":"1581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.10649999976158142,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.025699999183416367,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ciprofloxacin","display_name":"ciprofloxacin","score":0.8600000143051147},{"id":"https://openalex.org/keywords/dry-powder-inhalation","display_name":"dry powder inhalation","score":0.847000002861023},{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6919999718666077},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.8690000176429749},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.7490000128746033},{"id":"https://openalex.org/keywords/twice-daily-dosing","display_name":"twice-daily dosing","score":0.8450000286102295},{"id":"https://openalex.org/keywords/drug-accumulation","display_name":"drug accumulation","score":0.4790000021457672},{"id":"https://openalex.org/keywords/bitter-taste","display_name":"bitter taste","score":0.578000009059906},{"id":"https://openalex.org/keywords/bronchospasm","display_name":"bronchospasm","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6039999723434448},{"id":"https://openalex.org/keywords/adult-cystic-fibrosis","display_name":"adults with cystic fibrosis","score":0.7739999890327454},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9014743566513062},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8971835374832153},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.7911217212677002},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6924301385879517},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.6566329002380371},{"id":"https://openalex.org/C2777419714","wikidata":"https://www.wikidata.org/wiki/Q1334805","display_name":"Dry-powder inhaler","level":4,"score":0.5836179852485657},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5427674055099487},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5355714559555054},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.4571641683578491},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45066866278648376},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.3823707103729248},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3635103106498718},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3393293023109436},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.1858636438846588},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.14599886536598206},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0733247697353363},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002939","descriptor_name":"Ciprofloxacin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003550","descriptor_name":"Cystic Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011208","descriptor_name":"Powders","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012129","descriptor_name":"Respiratory Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058995","descriptor_name":"Dry Powder Inhalers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clinthera.2013.08.003","doi":"https://doi.org/10.1016/j.clinthera.2013.08.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2013.08.003","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},{"id":"pmid:24054830","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24054830","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical therapeutics","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1016/j.clinthera.2013.08.003","doi":"https://doi.org/10.1016/j.clinthera.2013.08.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.clinthera.2013.08.003","pdf_url":null,"source":{"id":"https://openalex.org/S185879095","display_name":"Clinical Therapeutics","issn_l":"0149-2918","issn":["0149-2918","1879-114X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W150542388","https://openalex.org/W1607515676","https://openalex.org/W1947930037","https://openalex.org/W1999008330","https://openalex.org/W2000173078","https://openalex.org/W2015515862","https://openalex.org/W2028213520","https://openalex.org/W2054114503","https://openalex.org/W2055857822","https://openalex.org/W2058889783","https://openalex.org/W2074235114","https://openalex.org/W2075069205","https://openalex.org/W2082031673","https://openalex.org/W2088783507","https://openalex.org/W2089590453","https://openalex.org/W2091042844","https://openalex.org/W2097575804","https://openalex.org/W2098507554","https://openalex.org/W2099261044","https://openalex.org/W2112593571","https://openalex.org/W2114243674","https://openalex.org/W2114632070","https://openalex.org/W2116478659","https://openalex.org/W2120906057","https://openalex.org/W2123796047","https://openalex.org/W2146799440","https://openalex.org/W2149627743","https://openalex.org/W2152510108","https://openalex.org/W2163025649","https://openalex.org/W2165433253","https://openalex.org/W2169675659","https://openalex.org/W3023225830"],"related_works":["https://openalex.org/W2130614237","https://openalex.org/W1492748501","https://openalex.org/W2315286742","https://openalex.org/W2013055972","https://openalex.org/W2256748050","https://openalex.org/W7099097358","https://openalex.org/W4408167556","https://openalex.org/W1993019338","https://openalex.org/W2327592597","https://openalex.org/W4200399828"],"abstract_inverted_index":{"BACKGROUND:":[0],"Inhaled":[1],"antibacterial":[2,57],"agents":[3],"are":[4],"used":[5],"to":[6,55,243,306,364,410],"manage":[7],"chronic":[8,103],"pulmonary":[9,100],"infections":[10],"in":[11,77,90,167,194,254,302,323],"cystic":[12],"fibrosis":[13],"(CF)":[14],"and":[15,59,67,73,102,164,177,181,228,247,251,277,291,331,350,379,382],"non-CF":[16],"bronchiectasis.":[17],"However,":[18],"established":[19],"nebulized":[20],"preparations":[21],"impose":[22],"a":[23,52],"substantial":[24,263,316],"time":[25],"burden":[26],"on":[27],"patients.":[28],"A":[29,82],"dry":[30],"powder":[31],"formulation":[32],"of":[33,70,262,298,311,341,377],"ciprofloxacin":[34,75,110,169,244,283,312,320,342,391],"for":[35,117,127,139,399,421],"inhalation":[36],"(ciprofloxacin":[37],"DPI)":[38],"has":[39],"been":[40],"developed":[41],"using":[42,51],"PulmoSphere\u2122":[43],"(Novartis,":[44],"Pharma":[45],"AG,":[46],"Basel,":[47],"Switzerland)":[48],"technology":[49],"(administered":[50],"T-326":[53],"inhaler)":[54],"maximize":[56],"activity":[58],"convenience.":[60],"OBJECTIVE:":[61],"This":[62],"study":[63,89],"investigated":[64],"the":[65,168,271,338,395,411,419],"tolerability":[66,195],"pharmacokinetic":[68],"properties":[69],"multiple-dose":[71],"once-daily":[72],"twice-daily":[74],"DPI":[76,111,170,235,284,343,357,405],"adults":[78],"with":[79,92,282,315,362,367,372,383],"CF.":[80],"METHODS:":[81],"Phase":[83],"I,":[84],"randomized,":[85],"single-blind,":[86],"placebo-controlled,":[87],"dose-escalation":[88],"patients":[91,149,166,204],"CF":[93],"(median":[94],"age":[95],"29.0":[96,156],"years":[97,157],"[19-40]),":[98],"stable":[99],"status,":[101],"Pseudomonas":[104],"aeruginosa":[105,401],"colonization.":[106],"Sequential":[107],"cohorts":[108],"received":[109],"32.5":[112,133,171,178,285,292,344,351],"mg":[113,123,134,172,175,179,279,286,289,293,345,348,352],"qd":[114,124],"(1":[115],"capsule":[116],"inhalation;":[118,128],"n":[119,129,206,210],"=":[120,130,136,207,211],"6),":[121,131],"65":[122,174,288,347],"(2":[125],"capsules":[126],"or":[132,190],"(n":[135],"6)":[137],"bid":[138,180],"7":[140,165],"days.":[141],"Each":[142],"group":[143],"was":[144,236,245,304,358],"placebo":[145,182],"controlled.":[146],"RESULTS:":[147],"Twenty-five":[148],"were":[150,201,274,313,326,402],"enrolled":[151],"(12":[152],"men;":[153],"median":[154],"age,":[155],"[range,":[158],"19-40":[159],"years];":[160],"6,":[161,162,163],"qd,":[173,176,287,290,346,349],"groups,":[183,258],"respectively).":[184],"No":[185],"serious":[186],"treatment-emergent":[187,217],"adverse":[188,218],"events":[189],"clinically":[191],"relevant":[192],"changes":[193],"parameters,":[196],"including":[197,220],"lung":[198,365],"function":[199],"measurements,":[200],"reported.":[202],"Twenty-one":[203],"(ciprofloxacin,":[205,223,230],"17;":[208],"placebo,":[209,226,232],"4)":[212],"experienced":[213],"29":[214],"mild":[215],"drug-related":[216],"events,":[219],"bitter":[221],"taste":[222],"17":[224],"patients;":[225],"2)":[227],"bronchospasm":[229],"3;":[231],"2).":[233],"Ciprofloxacin":[234,356,404],"absorbed":[237],"rapidly":[238],"after":[239,270,337],"inhalation.":[240],"Systemic":[241],"exposure":[242,370],"low":[246],"comparable":[248],"between":[249],"single":[250],"multiple":[252],"dosing":[253],"all":[255],"3":[256],"dose":[257,273,340],"suggesting":[259],"an":[260],"absence":[261],"drug":[264],"accumulation.":[265],"The":[266,296],"geometric":[267,299],"mean":[268,300,319],"AUCs":[269],"last":[272,339],"0.383,":[275],"1.472,":[276],"0.781":[278],"\u00b7":[280],"h/L":[281],"bid,":[294,353],"respectively.":[295,354],"range":[297],"t(\u00bd)":[301],"plasma":[303],"3.4":[305],"9.5":[307],"hours.":[308],"Sputum":[309,390],"concentrations":[310,321,392,416],"high,":[314],"variability.":[317],"Geometric":[318],"(%CV)":[322],"induced":[324],"sputum":[325],"57.7":[327],"(118.2),":[328],"177.5":[329],"(53.4),":[330],"149.7":[332],"(249.7)":[333],"mg/L":[334],"0.75":[335],"hours":[336],"CONCLUSIONS:":[355],"well":[359],"tolerated,":[360],"especially":[361],"respect":[363],"function,":[366],"minimal":[368],"systemic":[369,422],"compared":[371],"data":[373],"from":[374],"previous":[375],"studies":[376],"oral":[378],"intravenous":[380],"administration,":[381],"no":[384],"apparent":[385],"accumulation":[386],"at":[387,413],"steady":[388],"state.":[389],"above":[393],"100-times":[394],"minimum":[396],"inhibitory":[397],"concentration":[398],"P":[400],"detected.":[403],"may":[406],"be":[407],"effectively":[408],"delivered":[409],"lungs":[412],"microbiologically":[414],"active":[415],"while":[417],"minimizing":[418],"risk":[420],"intolerabilities.":[423],"Eudra":[424],"clinical":[425],"trial":[426],"identifier:":[427],"2006-003690-26.":[428]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}